Director records verified

Milind Raman Godbole

Named in 26 filings across 1 BSE-listed company since 2025-12 — most recently at Exato Technologies Ltd (2026-08).
Records through 2026-08-25 · refreshed as new filings arrive
Seen in filings at (from BSE disclosures)
Exato Technologies Ltd
director
26 filings · 2025-12 – 2026-08
Documented roles (from public records)
GeBBS Healthcare Solutions
Board Member / Senior Advisor (per AGM Notice FY2023-24 bearing his DIN 00471609 signature) · At least as of August 2024
Anza Medicode India Private Limited
Director · Not specified
Milanj Creations LLP
Director / Partner · Not specified
Exato Technologies Limited
Non-Executive Non-Independent Director · 2025-present (postal ballot concluded May 30, 2026)
Common questions (from the filings record)
Who is Milind Raman Godbole in BSE filings?
Milind Raman Godbole is named in 26 filings across 1 BSE-listed company since 2025-12 — most recently at Exato Technologies Ltd (2026-08). Records through 2026-08-25, from public exchange disclosures.
Which companies is Milind Raman Godbole named in?
Exato Technologies Ltd (director) — 26 filings, 2025-12 to 2026-08.
What documented roles does Milind Raman Godbole hold?
From BSE filings: director at Exato Technologies Ltd. From public records: GeBBS Healthcare Solutions — Board Member / Senior Advisor (per AGM Notice FY2023-24 bearing his DIN 00471609 signature), At least as of August 2024; Anza Medicode India Private Limited — Director, Not specified; Milanj Creations LLP — Director / Partner, Not specified; Exato Technologies Limited — Non-Executive Non-Independent Director, 2025-present (postal ballot concluded May 30, 2026).
Track record, connections and full analysis — on the Bench
The Bench shows this person's documented history, their connections across listed companies, and what happened after their filings.
Special Situations Bench a Humdinger HQ product
Compiled from public exchange disclosures and public records. situations.humdingerhq.ai is not a SEBI-registered research analyst; nothing here is investment advice. Corrections: via Humdinger HQ.